RCAT reflects symptom control and quality of life in allergic rhinoconjunctivitis patients

ConclusionThe strong correlation suggests that the RCAT alone is equivalent to the RQLQ with respect to patients’ symptom control and quality of life. Patients with uncontrolled symptoms can be identified using the RCAT. Hence, the physician can decide whether symptomatic therapy can be intensified or allergy immunotherapy should be administered.This article is protected by copyright. All rights reserved.

Source: Allergy - November 21, 2017 Category: Allergy & Immunology Authors: J. ‐P. Liedtke, A. Mandl, J. Köther, J. Chwieralski, K. Shah‐Hosseini, U. Pieper‐Fürst, S. Allekotte, R. Mösges Tags: Original Article: Airway Diseases Source Type: research